The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
Sep 15, 2025, 9:34 AM EDT
GCAN Market Cap
GCAN has a market cap or net worth of $404.97 thousand as of September 15, 2025. Its market cap has decreased by -22.57% in one year.
Market Cap
404.97K
Enterprise Value
661.53K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 2018, GCAN's market cap has decreased from 4.11M to 404.97K, a decrease of -90.15%. That is a compound annual growth rate of -28.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 404.97K | 25.82% |
| Dec 31, 2024 | 321.86K | -51.31% |
| Dec 29, 2023 | 661.03K | 64.05% |
| Dec 30, 2022 | 402.95K | -74.44% |
| Dec 31, 2021 | 1.58M | 13.07% |
| Dec 31, 2020 | 1.39M | 13.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |